Abstract
Glomerular protein permeability rises in nephrotic syndrome and may result from the effect of an unidentified “circulating factor.” The effect of this “circulating factor” on the permeability of other body membranes is unknown. In this study we examine the peritoneal membrane protein permeability in patients with nephrotic syndrome on chronic-cycler peritoneal dialysis. We conducted a retrospective study of peritoneal protein losses in the dialysate effluent of 60 pediatric peritoneal dialysis patients (ages 5.1–22 years) over a 6-year period (January 1997–December 2002). Nineteen patients had steroid-resistant nephrotic syndrome (SRNS), while 41 had other non-nephrotic etiologies of renal failure. Total and normalized peritoneal protein losses are higher in SRNS than in non-nephrotic patients (12,603±5,403 mg/day vs 4,475±469 mg/day, P<0.05; 297.8±79.3 mg/kg per day vs 156.8±16.0 mg/kg per day, P<0.05; 9,614.6±3,253.4 mg/m2 per day vs 4,168.3±367.3 mg/m2 per day, P<0.05). The ratio of total protein in dialysate to plasma, a measure of peritoneal membrane protein permeability, was higher in SRNS patients (3.50±1.00% vs 0.68±0.06%, P<0.001). Serum albumin concentration was lower in SRNS patients (3.09±0.13 mg/dl vs 3.52±0.07 mg/dl, P<0.01). There were no differences between the two groups with regard to duration of peritoneal dialysis, dialysis prescription, numbers of peritonitis episodes, catheter replacements, or hospitalizations. In summary, these results demonstrate that peritoneal protein losses in patients with SRNS are twice as great as in those without nephrotic syndrome. These results are consistent with the systemic effect of a “circulating factor” in SRNS and underscore the importance of adequate protein intake in patients on peritoneal dialysis.
Similar content being viewed by others
References
Vernier RL (1987) Primary nephrotic syndrome. In: Holliday MA, Barratt TM, Vernier RL (eds) Pediatric nephrology, 2nd edn, Williams & Williams, Baltimore, pp 448–452
Winetz JA, Robertson CR, Golbetz HV, Carrie BJ, Salyer WR, Myers BD (1981) The nature of the glomerular injury in minimal change and focal sclerosing glomerulopathies. Am J Kidney Dis 1:91–98
Nash MD, Edelman CM, Bernstein J, Barnett HL (1992) The nephrotic syndrome. In: Edelman CM (ed) Pediatric kidney disease, 2nd edn, Little, Brown, Boston, pp 1247–1254
International Study of Kidney Disease in Childhood (1979) “Nephrotic syndrome in Children.” A randomized trial comparison of two prednisone regimens in steroid responsive patients who relapse early. J Pediatr 95:239
Feld SM, Figueroa P, Savin V, Nast CC, Sharma R, Sharma M, Hirschberg R, Adler SG (1988) Plasmapheresis in the treatment of steroid-resistant focal and segmental glomerulosclerosis in native kidneys. Am J Kidney Dis 32:230–237
Artero ML, Sharma R, Savin VJ, Vincenti F (1994) Plasmapheresis reduces proteinuria and serum capacity to injure glomeruli in patients with recurrent focal glomerulosclerosis. Am J Kidney Dis 23:574–581
Sharma M, Sharma R, Reddy SR, McCarthy ET, Savin VJ (2002) Proteinuria after injection of human focal segmental glomerulosclerosis factor. Transplantation 73:366–372
Quan A, Baum M (1996) Protein losses in children on continuous cycler peritoneal dialysis. Pediatr Nephrol 10:728–731
Ellis D, Kapur S, Antonovych TT, Salcedo JR, Yunis EJ (1978) Focal glomerulosclerosis in children: correlation of histology with prognosis. J Pediatr 93:762–768
Mellits ED, Cheek DB (1970) The assessment of body water and fatness from infancy to adulthood. Monogr Soc Res Child Dev 35:12–26
Cameron JS, Turner DR, Ogg CS, Chantler C, Williams DG (1978) The long term prognosis of patients with focal segmental glomerulosclerosis. Clin Nephrol 10:213–218
Hoyer JR, Vernier RL, Najarian JS, Raij L, Simmons RL, Michael AF (1972) Recurrence of idiopathic focal segmental glomerulosclerosis in children. Lancet 2:343–348
Malekzadeh MH, Heuser ET, Ettenger RB, Pennisi AJ, Uittenbogaart CH, Warshaw BL, Fine RN (1979) Focal glomerulosclerosis and renal transplantation. J Pediatr 95:249–254
Lewis EJ (1982) Recurrent focal sclerosis after renal transplantation. Kidney Int 22:315–323
Verani RR, Hawkins EP (1986) Recurrent focal segmental glomerulosclerosis: a pathological study of the early lesion. Am J Nephrol 6:263–270
Morales JM, Andres A, Prieto C, Martinez MA, Praga M, Ruilope LM, Gutierrez Millet V, Rodicio JL (1988) Clinical and histological sequence of recurrent focal segmental glomerulosclerosis. Nephron 48:241–242
Savin VJ, Sharma R, Sharma M, McCarthy ET, Swan SK, Ellis E, Lovell H, Warady B, Gunwar S, Chonko AM, Artero M, Vincenti F (1996) Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med 334:878–883
Senggutuvan P, Cameron JS, Hartley RB, Rigden S, Chantler C, Haycock G, Williams DG, Ogg C, Koffman G (1990) Recurrence of focal segmental glomerulosclerosis in transplanted kidneys: analysis of incidence and risk factors in 59 allografts. Pediatr Nephrol 4:21–28
Munoz J, Sanchez M, Perez-Garcia R, Anaya F, Valderrabano F (1985) Recurrent focal segmental glomerulosclerosis in renal transplants. Proteinuria relapsing following plasma exchange. Clin Nephrol 24:213–214
Laufer J, Ettenger RB, Ho WG, Cohen AH, Marik JL, Fine RN (1988) Plasma exchange for recurrent nephrotic syndrome following renal transplantation. Transplantation 46:540–542
Dantal J, Bigot E, Bogers W, Testa A, Kriaa F, Jacques Y, Hurault de Ligny B, Niaudet P, Charpentier B, Soulillou JP (1994) Effect of plasma protein adsorption on protein excretion in kidney transplant recipients with recurrent nephrotic syndrome. N Eng J Med 330:7–14
Dantal J, Godfrin Y, Koll R, Perretto S, Jaulet J, Bouhours JF, Soulillou JP (1988) Antihuman immunoglobulin affinity immunoabsorption strongly decreases proteinuria in patients with relapsing nephrotic syndrome. J Am Soc Nephrol 9:1709
Fried L, Piraino B (2000) Peritonitis. In: Gokal R, Khanna R, Krediet R, Noph K (eds) Textbook of peritoneal dialysis, 2nd edn, Kluwer, Boston, pp 545–598
Rubin J, Ray R, Barnes T, Bower J (1981) Peritoneal abnormalities during infectious episodes of continuous ambulatory peritoneal dialysis. Nephron 29:124–127
Blumenkrantz MJ, Gahl GM, Kopple JD, Kamdar AV, Jones MR, Kessel M, Coburn JW (1981) Protein loss during peritoneal dialysis. Kidney Int 19:593–602
Burkart JM (2000) Adequacy of peritoneal dialysis. In: Gokal R, Khanna R, Krediet R, Nolph K (eds) Textbook of peritoneal dialysis, 2nd edn, Kluwer Academic, Boston, pp 467–470
Schaefer F, Klaus G, Mehls O (1999) Peritoneal transport properties and dialysis dose affect growth and nutritional status in children on chronic peritoneal dialysis. Mid-European Pediatric Peritoneal Dialysis Study Group. J Am Soc Nephrol 10:1786–1792
de Boer AW, Schröder CH, Reddingius RE, Willems HL, Monnens LAH (1988) Peritoneal protein loss in children with nephrotic syndrome during peritoneal dialysis. Nephrol Dial Transplant 13:2348–2350
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kopanati, S., Baum, M. & Quan, A. Peritoneal protein losses in children with steroid-resistant nephrotic syndrome on continuous-cycler peritoneal dialysis. Pediatr Nephrol 21, 1013–1019 (2006). https://doi.org/10.1007/s00467-006-0012-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-006-0012-y